Dipyridamole
Links shared publicly online about this topic
Cardiology Medical News about Dipyridamole
mdlinx.com — “Safety of fixed-dose aspirin"extended-release dipyridamole in patients with ischemic heart disease” View full resource at mdlinx.com
Most Recently Shared on April 28, 2010 at 9:05 am By:
Safety of fixed-dose aspirin–extended-release dipyridamole in patients with ischemic heart disease:... http://bit.ly/bfgmoA #cardio #mdlinx
Cardiology News & Articles - MDLinx - Dipyridamole on #MDlinx
mdlinx.com — “Cardiology News & Articles - MDLinx - Dipyridamole on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 26, 2010 at 6:44 pm By:
Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin: Cardi... http://bit.ly/b6kmwF #cardio #mdlinx
DIPYRIDAMOLE - ORAL (Persantine) side effects, medical uses, and drug interactions.
medicinenet.com — “Consumer information about the medication DIPYRIDAMOLE - ORAL (Persantine), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the prescription drug DIPYRIDAMOLE - ORAL.” View full resource at medicinenet.com
Most Recently Shared on September 23, 2010 at 7:25 am By:
MedicineNet: dipyridamole - oral, Persantine http://bit.ly/atxyBv Full http://bit.ly/dtuhb7
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial : The Lancet Neurology
thelancet.com — “Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endp...” View full resource at thelancet.com
Most Recently Shared on January 21, 2010 at 12:10 am By:
Early use of ASA and dipiridamole within 24 h of symptoms onset - similar safety as starting Rx 1 wk after - http://bit.ly/4WxVD1
No significant reduction of CV events with aspirin in peripheral artery disease
theheart.org — “A meta-analysis of trials assessing the effects of aspirin with or without dipyridamole in patients with PAD finds no significant benefit in reducing overall cardiovascular events, although there was a significant reduction in stroke as a secondary end point.” View full resource at theheart.org
Most Recently Shared on May 13, 2009 at 9:25 pm By:
heartwire: No significant reduction of CV events with aspirin in peripheral artery disease http://bit.ly/aS6jA
Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events : The Lancet Neurology
thelancet.com — “Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. By - Graeme J Hankey FRACP, John W Eikelboom FRACP” View full resource at thelancet.com
Most Recently Shared on February 26, 2010 at 12:19 am By:
Antithrombotic drugs to treat TIA and ischemic stroke - http://bit.ly/cmBc6n
Cardiology Medical News about Caffeine
mdlinx.com — “Incidence of Caffeine in Serum of Patients Undergoing Dipyridamole Myocardial Perfusion Stress Test by an Intensive Versus Routine Caffeine History Screening” View full resource at mdlinx.com
Most Recently Shared on May 15, 2010 at 9:05 pm By:
Incidence of Caffeine in Serum of Patients Undergoing Dipyridamole Myocardial Perfusion Stress Test... http://bit.ly/9ZCItY #cardio #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
Advertisement

